178 related articles for article (PubMed ID: 31241979)
1. Deletion of organic cation transporter Oct3 promotes hepatic fibrosis via upregulation of TGFβ.
Vollmar J; Kim YO; Marquardt JU; Becker D; Galle PR; Schuppan D; Zimmermann T
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G195-G202. PubMed ID: 31241979
[TBL] [Abstract][Full Text] [Related]
2. Functional inhibition of Oct leads to HNF4α upregulation.
Vollmar J; Kim YO; Marquardt JU; Galle PR; Schuppan D; Zimmermann T
Exp Ther Med; 2021 Apr; 21(4):349. PubMed ID: 33732322
[TBL] [Abstract][Full Text] [Related]
3. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.
Nies AT; Koepsell H; Winter S; Burk O; Klein K; Kerb R; Zanger UM; Keppler D; Schwab M; Schaeffeler E
Hepatology; 2009 Oct; 50(4):1227-40. PubMed ID: 19591196
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance.
Heise M; Lautem A; Knapstein J; Schattenberg JM; Hoppe-Lotichius M; Foltys D; Weiler N; Zimmermann A; Schad A; Gründemann D; Otto G; Galle PR; Schuchmann M; Zimmermann T
BMC Cancer; 2012 Mar; 12():109. PubMed ID: 22439694
[TBL] [Abstract][Full Text] [Related]
5. Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesis.
Vollmar J; Lautem A; Closs E; Schuppan D; Kim YO; Grimm D; Marquardt JU; Fuchs P; Straub BK; Schad A; Gründemann D; Schattenberg JM; Gehrke N; Wörns MA; Baumgart J; Galle PR; Zimmermann T
Oncotarget; 2017 Dec; 8(70):115667-115680. PubMed ID: 29383190
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma.
Lautem A; Heise M; Gräsel A; Hoppe-Lotichius M; Weiler N; Foltys D; Knapstein J; Schattenberg JM; Schad A; Zimmermann A; Otto G; Lang H; Galle PR; Schuchmann M; Zimmermann T
Int J Oncol; 2013 Apr; 42(4):1297-304. PubMed ID: 23440379
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
Patsenker E; Popov Y; Stickel F; Jonczyk A; Goodman SL; Schuppan D
Gastroenterology; 2008 Aug; 135(2):660-70. PubMed ID: 18538673
[TBL] [Abstract][Full Text] [Related]
8. Mast Cells Induce Ductular Reaction Mimicking Liver Injury in Mice Through Mast Cell-Derived Transforming Growth Factor Beta 1 Signaling.
Kyritsi K; Kennedy L; Meadows V; Hargrove L; Demieville J; Pham L; Sybenga A; Kundu D; Cerritos K; Meng F; Alpini G; Francis H
Hepatology; 2021 Jun; 73(6):2397-2410. PubMed ID: 32761972
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1 and TGF-β2 abundance in liver diseases of mice and men.
Dropmann A; Dediulia T; Breitkopf-Heinlein K; Korhonen H; Janicot M; Weber SN; Thomas M; Piiper A; Bertran E; Fabregat I; Abshagen K; Hess J; Angel P; Coulouarn C; Dooley S; Meindl-Beinker NM
Oncotarget; 2016 Apr; 7(15):19499-518. PubMed ID: 26799667
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
11. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
[TBL] [Abstract][Full Text] [Related]
12. Thymosin β4 suppresses CCl
Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
[TBL] [Abstract][Full Text] [Related]
13. Pituitary tumor transforming gene as a novel regulatory factor of liver fibrosis.
Buko V; Belonovskaya E; Naruta E; Lukivskaya O; Kanyuka O; Zhuk O; Kranc R; Stoika R; Sybirna N
Life Sci; 2015 Jul; 132():34-40. PubMed ID: 25936962
[TBL] [Abstract][Full Text] [Related]
14. Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice.
An SY; Jang YJ; Lim HJ; Han J; Lee J; Lee G; Park JY; Park SY; Kim JH; Do BR; Han C; Park HK; Kim OH; Song MJ; Kim SJ; Kim JH
Gastroenterology; 2017 Apr; 152(5):1174-1186. PubMed ID: 27956229
[TBL] [Abstract][Full Text] [Related]
15. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis.
Uchinami H; Seki E; Brenner DA; D'Armiento J
Hepatology; 2006 Aug; 44(2):420-9. PubMed ID: 16871591
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein related protein 1 knockdown attenuates hepatic fibrosis via the regulation of MMPs/TIMPs in mice.
Ren JJ; Huang TJ; Zhang QQ; Zhang HY; Guo XH; Fan HQ; Li RK; Liu LX
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):38-47. PubMed ID: 30243878
[TBL] [Abstract][Full Text] [Related]
17. The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice.
Wu N; Meng F; Invernizzi P; Bernuzzi F; Venter J; Standeford H; Onori P; Marzioni M; Alvaro D; Franchitto A; Gaudio E; Glaser S; Alpini G
Hepatology; 2016 Sep; 64(3):865-79. PubMed ID: 27115285
[TBL] [Abstract][Full Text] [Related]
18. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis.
Canbay A; Higuchi H; Bronk SF; Taniai M; Sebo TJ; Gores GJ
Gastroenterology; 2002 Oct; 123(4):1323-30. PubMed ID: 12360492
[TBL] [Abstract][Full Text] [Related]
19. Early growth response factor-1 limits biliary fibrosis in a model of xenobiotic-induced cholestasis in mice.
Sullivan BP; Cui W; Copple BL; Luyendyk JP
Toxicol Sci; 2012 Mar; 126(1):267-74. PubMed ID: 22094456
[TBL] [Abstract][Full Text] [Related]
20. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
Popov Y; Patsenker E; Stickel F; Zaks J; Bhaskar KR; Niedobitek G; Kolb A; Friess H; Schuppan D
J Hepatol; 2008 Mar; 48(3):453-64. PubMed ID: 18221819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
